StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > US Symbol change

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Jul 12, 2021 3:38pm

176 Views

Post# 33530807

RE:RE:RE:US Symbol change

At the bottom of the news release:

https://stockhouse.com/news/press-releases/2021/06/02/stagezero-life-sciences-offers-drive-up-covid-19-pcr-travel-testing-with

Media Contact
Kristin Villiotte
SHIFT Communications
kvilliotte@shiftcomm.com

----------
On the website under this tab:

https://www.stagezerolifesciences.com/customer-support.html

The email associated with partnership inquiries was originally M.Osullivan@ stagezerols going to Meghan O'Sullivan of O'Sullivan Communications.

TitleConsultant

Dates EmployedAug 2010 – Present

Employment Duration11 yrs

LocationMassachussetts

Interimarketing™ is a branded offering of O'Sullivan Communications, Inc. that provides interim marketing and commercialization services to companies in the healthcare, medical device and molecular diagnostic industries. Interimarketing provides comprehensive, go-to-market strategies that build awareness, generate leads and support sales.

" We understand that healthcare companies face many challenges in today's market. Your value propositions have to appeal to multiple constituencies including physicians, payers, health systems, and ultimately patients. That's why you need a partner that understands the changing market dynamics and metrics that drive today's decision making. We can help position your products, services and the stories about them in order to answer a very critical question on every prospect's mind, 'Are you strategically important?' We'll make sure the answer is, "Yes."

- Meghan O'Sullivan…
TitleFounder and President

Dates Employed1991 – Present

Employment Duration30 yrs

O’Sullivan has extensive experience in branding as well as category marketing and has developed the strategy and tactics behind the firm’s most successful integrated marketing programs. In addition to leading the strategy and creative execution for new product launches and brand repositioning, O’Sullivan has stepped in as an interim director of marketing to help her clients develop results-driven, cost-effective marketing programs. Under her leadership, the firm has launched and implemented marketing campaigns for clients in a cross section of industries including healthcare, medical device, consumer technology, economic development and professional services.

It has since been changed to the distribution group support @.

---------------

The company recently moved from the greys to the pinks on the US OTC and this morning the symbol changed.

-------